Combined Targeting of NAD Biosynthesis and the NAD-dependent Transcription Factor C-terminal Binding Protein as a Promising Novel Therapy for Pancreatic Cancer

Cancer therapies targeting metabolic derangements unique to cancer cells are emerging as a key strategy to address refractory solid tumors such as pancreatic ductal adenocarcinomas (PDAC) that exhibit resistance to extreme nutrient deprivation in the tumor microenvironment. Nicotinamide adenine dinu...

Descripción completa

Detalles Bibliográficos
Autores principales: Dcona, M. Michael, Chougoni, Kranthi Kumar, Dcona, Diana T., West, Jacqueline L., Singh, Sahib J., Ellis, Keith C., Grossman, Steven R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10549224/
https://www.ncbi.nlm.nih.gov/pubmed/37707363
http://dx.doi.org/10.1158/2767-9764.CRC-22-0521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10549224/
https://www.ncbi.nlm.nih.gov/pubmed/37707363
http://dx.doi.org/10.1158/2767-9764.CRC-22-0521

Ejemplares similares